SB-200646

Chemical compound
  • none
Legal statusLegal status
  • UN: Unscheduled
Identifiers
  • 1-(1-Methyl-1H-indol-5-yl)-3-pyridin-3-ylurea
CAS Number
  • 143797-63-1 checkY
PubChem CID
  • 126769
ChemSpider
  • 112592
KEGG
  • C11739
ChEBI
  • CHEBI:8976
ChEMBL
  • ChEMBL85194
CompTox Dashboard (EPA)
  • DTXSID40162550 Edit this at Wikidata
Chemical and physical dataFormulaC15H14N4OMolar mass266.304 g·mol−13D model (JSmol)
  • Interactive image
  • Cn1ccc2c1ccc(c2)NC(=O)Nc3cccnc3
InChI
  • InChI=1S/C15H14N4O/c1-19-8-6-11-9-12(4-5-14(11)19)17-15(20)18-13-3-2-7-16-10-13/h2-10H,1H3,(H2,17,18,20)
  • Key:OJZZJTLBYXHUSJ-UHFFFAOYSA-N

SB-200646 is a 5-HT2 receptor antagonist with anxiolytic properties in rats. It was the first 5-HT2 antagonist discovered to have selectivity of 5-HT2C/2B over 5-HT2A.[1]

References

  1. ^ Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP (March 1994). "In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist". British Journal of Pharmacology. 111 (3): 797–802. doi:10.1111/j.1476-5381.1994.tb14808.x. PMC 1910094. PMID 7912626.
  • v
  • t
  • e
Serotonin receptor modulators
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins